Drug treatment strategies for secondary lymphedema
Secondary lymphedema is a chronic disease caused by lymphatic system dysfunction, which affects about 140 to 250 million people worldwide and has the second highest incidence among disabling diseases. With the advancement of malignant tumor treatment technology and the acceleration of the aging proc...
Saved in:
Main Authors: | Fu Yongda, Duan Man, Pu Luya, Du Jianshi |
---|---|
Format: | Article |
Language: | Chinese |
Published: |
Editorial Office of International Journal of Geriatrics
2025-07-01
|
Series: | Guoji laonian yixue zazhi |
Subjects: | |
Online Access: | http://gwll.publish.founderss.cn/thesisDetails#10.3969/j.issn.1674-7593.2025.04.001&lang=en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Upper limb lymphedema treatment application
by: Geraldo Magela Salomé, et al.
Published: (2023-10-01) -
Reprogramming lymphatic endothelial glucose metabolism for the treatment of lymphangiogenesis-related disease
by: Ziran Zhang, et al.
Published: (2025-08-01) -
Polymorphism of angiogenesis regulation factor genes (<i>VEGF/VEGFR</i>), and extracellular matrix remodeling genes (<i>MMP/TIMP</i>), and the levels of their products in extracellular tissues of patients with primary and secondary lymphedema
by: V. I. Konenkov, et al.
Published: (2024-07-01) -
Lymphedema after combination treatment of head and neck tumors
by: A. M. Stepanova, et al.
Published: (2018-07-01) -
Successful Surgical Treatment of Coronavirus Disease 2019 (COVID-19) Vaccination Related Upper Extremity Lymphedema: Case Report
by: Hyung Hwa Jeong, et al.